PPA
SPRB

Parametric Portfolio Associates’s Spruce Biosciences SPRB Stock Holding History

Parametric Portfolio Associates’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$55K Sell
366
-496
-58% -$92.3K ﹤0.01% 3624
2021
Q4 		$288K Buy
+862
New +$257K ﹤0.01% 3299

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Parametric Portfolio Associates's SPRB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Spruce Biosciences (SPRB) stake by 58% in Q1 2022, selling an estimated $92.3K and leaving 366 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Parametric Portfolio Associates first reported a position in SPRB in Q4 2021 and has held it in 2 quarters since. The position peaked at $288K in Q4 2021. 43 funds tracked by Wall St. Rank hold SPRB as of Q1 2022.

  • Parametric Portfolio Associates held 366 shares of Spruce Biosciences worth $55K as of Q1 2022.
  • Parametric Portfolio Associates sold 496 Spruce Biosciences shares in Q1 2022, an estimated $92.3K.
  • Spruce Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3624 holding.
  • Parametric Portfolio Associates first reported a position in Spruce Biosciences in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Spruce Biosciences position peaked at $288K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.